Failed Controls, Firm Boundaries: Reading the Paperwork That Separates a Research Peptide from a Licensed Medicine
A failed in-vitro control run is rarely just an assay problem. It is a documentation event. Before retesting, researchers should establish whether the material on the bench is a research peptide supplied for laboratory use or a licensed medicine with a different paper trail. The distinction is not academic. Research-use-onlyContinue Reading